Workup and Management of Thyroid Nodules

References

1. • Jin J.
   • McHenry C.R.
   Thyroid incidentaloma.
   Best Pract Res Clin Endocrinol Metab. 2012; 26: 83-96https://doi.org/10.1016/j.beem.2011.06.004
   View in Article

   • Google Scholar
2. • Mortensen J.D.
   • Woolner L.B.
   • Bennett W.A.
   Gross and microscopic findings in clinically normal thyroid glands.
   J Clin Endocrinol Metab. 1955; 15: 1270-1280https://doi.org/10.1210/jcem-15-10-1270
   View in Article

   • Google Scholar
3. • Guth S.
   • Theune U.
   • Aberle J.
   • et al.
   Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination.
   Eur J Clin Invest. 2009; 39: 699-706https://doi.org/10.1111/j.1365-2362.2009.02162.x
   View in Article

   • Google Scholar
4. • Ahmed S.
   • Horton K.M.
   • Jeffrey Jr., R.B.
   • et al.
   Incidental thyroid nodules on chest CT: review of the literature and management suggestions.
   AJR Am J Roentgenol. 2010; 195: 1066-1071https://doi.org/10.2214/AJR.10.4506
   View in Article

   • Google Scholar
5. • Rad M.P.
   • Zakavi S.R.
   • Layegh P.
   • et al.
   Incidental thyroid abnormalities on carotid color doppler ultrasound: frequency and clinical significance.
   J Med Ultrasound. 2015; 23 (Available at:): 25-28
   https://www.sciencedirect.com/science/article/pii/S0929644114000769
   View in Article

   • Google Scholar
6. • Yoon D.Y.
   • Chang S.K.
   • Choi C.S.
   • et al.
   The prevalence and significance of incidental thyroid nodules identified on computed tomography.
   J Comput Assist Tomogr. 2008; 32: 810-815https://doi.org/10.1097/RCT.0b013e318157fd38
   View in Article

   • Google Scholar
7. • Cohen M.S.
   • Arslan N.
   • Dehdashti F.
   • et al.
   Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
   Surgery. 2001; 130: 941-946
   View in Article

   • Google Scholar
8. • Desser T.S.
   • Kamaya A.
   Ultrasound of thyroid nodules.
   Neuroimaging Clin N Am. 2008; 18 (vii): 463-478https://doi.org/10.1016/j.nic.2008.03.005
   View in Article

   • Google Scholar
9. • Davies L.
   • Welch H.G.
   Current thyroid cancer trends in the United States.
   JAMA Otolaryngol Head Neck Surg. 2014; 140: 317-322https://doi.org/10.1001/jamaoto.2014.1
   View in Article

   • Google Scholar
10. • Hoang J.K.
    • Nguyen X.V.
    • Davies L.
    Overdiagnosis of thyroid cancer: answers to five key questions.
    Acad Radiol. 2015; 22: 1024-1029
    View in Article

    • Google Scholar
11. • Kovatch K.J.
    • Hoban C.W.
    • Shuman A.G.
    Thyroid cancer surgery guidelines in an era of de-escalation.
    Eur J Surg Oncol. 2018; 44: 297-306
    View in Article

    • Google Scholar
12. • Bibbins-Domingo K.
    • Grossman D.C.
    • Curry S.J.
    • et al.
    • US Preventive Services Task Force
    Screening for thyroid cancer: US preventive services task force recommendation statement.
    JAMA. 2017; 317: 1882-1887https://doi.org/10.1001/jama.2017.4011
    View in Article

    • Google Scholar
13. • Kim B.W.
    • Yousman W.
    • Wong W.X.
    • et al.
    Less is more: comparing the 2015 and 2009 american thyroid association guidelines for thyroid nodules and cancer.
    Thyroid. 2016; 26: 759-764https://doi.org/10.1089/thy.2016.0068
    View in Article

    • Google Scholar
14. • Haugen B.R.
    • Alexander E.K.
    • Bible K.C.
    • et al.
    2015 american thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer.
    Thyroid. 2016; 26: 1-133https://doi.org/10.1089/thy.2015.0020
    View in Article

    • Google Scholar
15. • Ramundo V.
    • Sponziello M.
    • Falcone R.
    • et al.
    Low-risk papillary thyroid microcarcinoma: optimal management toward a more conservative approach.
    J Surg Oncol. 2020; 121: 958-963https://doi.org/10.1002/jso.25848
    View in Article

    • Google Scholar
16. • Welker M.J.
    • Orlov D.
    Thyroid nodules.
    Am Fam Physician. 2003; 67: 559-566
    View in Article

    • Google Scholar
17. • Popoveniuc G.
    • Jonklaas J.
    Thyroid nodules.
    Med Clin North Am. 2012; 96: 329-349https://doi.org/10.1016/j.mcna.2012.02.002
    View in Article

    • Google Scholar
18. • Haymart M.R.
    • Repplinger D.J.
    • Leverson G.E.
    • et al.
    Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.
    J Clin Endocrinol Metab. 2008; 93: 809-814
    View in Article

    • Google Scholar
19. • Lau L.W.
    • Ghaznavi S.
    • Frolkis A.D.
    • et al.
    Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis.
    Thyroid Res. 2021; 14: 3https://doi.org/10.1186/s13044-021-00094-1
    View in Article

    • Google Scholar
20. • Gharib H.
    • Papini E.
    Thyroid nodules: clinical importance, assessment, and treatment.
    Endocrinol Metab Clin North Am. 2007; 36 (vi): 707-735
    View in Article

    • Google Scholar
21. • Grani G.
    • Sponziello M.
    • Pecce V.
    • et al.
    Contemporary thyroid nodule evaluation and management.
    J Clin Endocrinol Metab. 2020; 105: 2869-2883
    View in Article

    • Google Scholar
22. • Nachiappan A.C.
    • Metwalli Z.A.
    • Hailey B.S.
    • et al.
    The thyroid: review of imaging features and biopsy techniques with radiologic-pathologic correlation.
    Radiographics. 2014; 34: 276-293https://doi.org/10.1148/rg.342135067
    View in Article

    • Google Scholar
23. • Shetty S.K.
    • Maher M.M.
    • Hahn P.F.
    • et al.
    Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology.
    AJR Am J Roentgenol. 2006; 187: 1349-1356
    View in Article

    • Google Scholar
24. • Hambly N.M.
    • Gonen M.
    • Gerst S.R.
    • et al.
    Implementation of evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards.
    AJR Am J Roentgenol. 2011; 196: 655-660https://doi.org/10.2214/AJR.10.4577
    View in Article

    • Google Scholar
25. • Tessler F.N.
    • Middleton W.D.
    • Grant E.G.
    • et al.
    ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee.
    J Am Coll Radiol. 2017; 14: 587-595
    View in Article

    • Google Scholar
26. • Salmaslioğlu A.
    • Erbil Y.
    • Dural C.
    • et al.
    Predictive value of sonographic features in preoperative evaluation of malignant thyroid nodules in a multinodular goiter.
    World J Surg. 2008; 32: 1948-1954https://doi.org/10.1007/s00268-008-9600-2
    View in Article

    • Google Scholar
27. • Kwak J.Y.
    • Han K.H.
    • Yoon J.H.
    • et al.
    Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk.
    Radiology. 2011; 260: 892-899https://doi.org/10.1148/radiol.11110206
    View in Article

    • Google Scholar
28. • Brito J.P.
    • Gionfriddo M.R.
    • Al Nofal A.
    • et al.
    The accuracy of thyroid nodule ultrasound to predict thyroid cancer: systematic review and meta-analysis.
    J Clin Endocrinol Metab. 2014; 99: 1253-1263https://doi.org/10.1210/jc.2013-2928
    View in Article

    • Google Scholar
29. • Kim J.Y.
    • Jung S.L.
    • Kim M.K.
    • et al.
    Differentiation of benign and malignant thyroid nodules based on the proportion of sponge-like areas on ultrasonography: Imaging-pathologic correlation.
    Ultrasonography. 2015; 34: 304-311https://doi.org/10.14366/usg.15016
    View in Article

    • Google Scholar
30. • Redman R.
    • Zalaznick H.
    • Mazzaferri E.L.
    • et al.
    The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules.
    Thyroid. 2006; 16: 55-60https://doi.org/10.1089/thy.2006.16.55
    View in Article

    • Google Scholar
31. • Robitschek J.
    • Straub M.
    • Wirtz E.
    • et al.
    Diagnostic efficacy of surgeon-performed ultrasound-guided fine needle aspiration: a randomized controlled trial.
    Otolaryngol Head Neck Surg. 2010; 142: 306-309https://doi.org/10.1016/j.otohns.2009.11.011
    View in Article

    • Google Scholar
32. • Gharib H.
    • Goellner J.R.
    Fine-needle aspiration biopsy of the thyroid: an appraisal.
    Ann Intern Med. 1993; 118: 282-289https://doi.org/10.7326/0003-4819-118-4-199302150-00007
    View in Article

    • Google Scholar
33. • de Koster E.J.
    • Kist J.W.
    • Vriens M.R.
    • et al.
    Thyroid ultrasound-guided fine-needle aspiration: the positive influence of on-site adequacy assessment and number of needle passes on diagnostic cytology rate.
    Acta Cytol. 2016; 60: 39-45https://doi.org/10.1159/000444917
    View in Article

    • Google Scholar
34. • Polyzos S.A.
    • Anastasilakis A.D.
    Clinical complications following thyroid fine-needle biopsy: a systematic review.
    Clin Endocrinol (Oxf). 2009; 71: 157-165https://doi.org/10.1111/j.1365-2265.2009.03522.x
    View in Article

    • Google Scholar
35. • Polyzos S.A.
    • Anastasilakis A.D.
    A systematic review of cases reporting needle tract seeding following thyroid fine needle biopsy.
    World J Surg. 2010; 34: 844-851https://doi.org/10.1007/s00268-009-0362-2
    View in Article

    • Google Scholar
36. • Denham S.L.
    • Ismail A.
    • Bolus D.N.
    • et al.
    Effect of anticoagulation medication on the thyroid fine-needle aspiration pathologic diagnostic sufficiency rate.
    J Ultrasound Med. 2016; 35: 43-48https://doi.org/10.7863/ultra.15.03044
    View in Article

    • Google Scholar
37. • Khadra H.
    • Kholmatov R.
    • Monlezun D.
    • et al.
    Do anticoagulation medications increase the risk of haematoma in ultrasound-guided fine needle aspiration of thyroid lesions?.
    Cytopathology. 2018; 29: 565-568https://doi.org/10.1111/cyt.12608
    View in Article

    • Google Scholar
38. • Lyle M.A.
    • Dean D.S.
    Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in patients taking novel oral anticoagulants.
    Thyroid. 2015; 25: 373-376https://doi.org/10.1089/thy.2014.0307
    View in Article

    • Google Scholar
39. • Bongiovanni M.
    • Spitale A.
    • Faquin W.C.
    • et al.
    The bethesda system for reporting thyroid cytopathology: a meta-analysis.
    Acta Cytol. 2012; 56: 333-339https://doi.org/10.1159/000339959
    View in Article

    • Google Scholar
40. • Nikiforov Y.E.
    • Seethala R.R.
    • Tallini G.
    • et al.
    Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors.
    JAMA Oncol. 2016; 2: 1023-1029https://doi.org/10.1001/jamaoncol.2016.0386
    View in Article

    • Google Scholar
41. • Geramizadeh B.
    • Maleki Z.
    Non-invasive follicular thyroid neoplasm with papillary-like nuclearfeatures (NIFTP): a review and update.
    Endocrine. 2019; 64: 433-440https://doi.org/10.1007/s12020-019-01887-z
    View in Article

    • Google Scholar
42. • Cibas E.S.
    • Ali S.Z.
    The 2017 bethesda system for reporting thyroid cytopathology.
    Thyroid. 2017; 27: 1341-1346https://doi.org/10.1089/thy.2017.0500
    View in Article

    • Google Scholar
43. • Saieg M.A.
    • Barbosa B.
    • Nishi J.
    • et al.
    The impact of repeat FNA in non-diagnostic and indeterminate thyroid nodules: a 5-year single-centre experience.
    Cytopathology. 2018; 29: 196-200https://doi.org/10.1111/cyt.12508
    View in Article

    • Google Scholar
44. • Ho A.S.
    • Sarti E.E.
    • Jain K.S.
    • et al.
    Malignancy rate in thyroid nodules classified as bethesda category III (AUS/FLUS).
    Thyroid. 2014; 24: 832-839https://doi.org/10.1089/thy.2013.0317
    View in Article

    • Google Scholar
45. • Brito J.P.
    • Ito Y.
    • Miyauchi A.
    • et al.
    A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma.
    Thyroid. 2016; 26: 144-149https://doi.org/10.1089/thy.2015.0178
    View in Article

    • Google Scholar
46. • Mazzaferri E.L.
    Management of low-risk differentiated thyroid cancer.
    Endocr Pract. 2007; 13: 498-512
    View in Article

    • Google Scholar
47. • Fradin J.M.
    ACR TI-RADS: an advance in the management of thyroid nodules or pandora's box of surveillance?.
    J Clin Ultrasound. 2020; 48: 3-6https://doi.org/10.1002/jcu.22772
    View in Article

    • Google Scholar
48. • Jensen C.B.
    • Saucke M.C.
    • Francis D.O.
    • et al.
    From overdiagnosis to overtreatment of low-risk thyroid cancer: a thematic analysis of attitudes and beliefs of endocrinologists, surgeons, and patients.
    Thyroid. 2020; 30: 696-703https://doi.org/10.1089/thy.2019.0587
    View in Article

    • Google Scholar
49. • Ajmal S.
    • Rapoport S.
    • Ramirez Batlle H.
    • et al.
    The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?.
    J Am Coll Surg. 2015; 220: 987-992
    View in Article

    • Google Scholar
50. • Lee S.
    • Skelton T.S.
    • Zheng F.
    • et al.
    The biopsy-proven benign thyroid nodule: is long-term follow-up necessary?.
    J Am Coll Surg. 2013; 217: 81-89
    View in Article

    • Google Scholar
51. • Alexander E.K.
    • Kennedy G.C.
    • Baloch Z.W.
    • et al.
    Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
    N Engl J Med. 2012; 367: 705-715https://doi.org/10.1056/NEJMoa1203208
    View in Article

    • Google Scholar
52. • Endo M.
    • Nabhan F.
    • Porter K.
    • et al.
    Afirma gene sequencing classifier compared with gene expression classifier in indeterminate thyroid nodules.
    Thyroid. 2019; 29: 1115-1124https://doi.org/10.1089/thy.2018.0733
    View in Article

    • Google Scholar
53. • Steward D.L.
    • Carty S.E.
    • Sippel R.S.
    • et al.
    Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study.
    JAMA Oncol. 2019; 5: 204-212https://doi.org/10.1001/jamaoncol.2018.4616
    View in Article

    • Google Scholar
54. • Labourier E.
    • Shifrin A.
    • Busseniers A.E.
    • et al.
    Molecular testing for miRNA, mRNA, and DNA on fine-needle aspiration improves the preoperative diagnosis of thyroid nodules with indeterminate cytology.
    J Clin Endocrinol Metab. 2015; 100: 2743-2750https://doi.org/10.1210/jc.2015-1158
    View in Article

    • Google Scholar
55. • Al-Qurayshi Z.
    • Deniwar A.
    • Thethi T.
    • et al.
    Association of malignancy prevalence with test properties and performance of the gene expression classifier in indeterminate thyroid nodules.
    JAMA Otolaryngol Head Neck Surg. 2017; 143: 403-408https://doi.org/10.1001/jamaoto.2016.3526
    View in Article

    • Google Scholar
56. • Baca S.C.
    • Wong K.S.
    • Strickland K.C.
    • et al.
    Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different afirma gene expression classifier results and clinical outcomes.
    Cancer Cytopathol. 2017; 125: 313-322https://doi.org/10.1002/cncy.21827
    View in Article

    • Google Scholar
57. • Marcadis A.R.
    • Valderrabano P.
    • Ho A.S.
    • et al.
    Interinstitutional variation in predictive value of the ThyroSeq v2 genomic classifier for cytologically indeterminate thyroid nodules.
    Surgery. 2019; 165: 17-24
    View in Article

    • Google Scholar
58. • Marti J.L.
    • Avadhani V.
    • Donatelli L.A.
    • et al.
    Wide inter-institutional variation in performance of a molecular classifier for indeterminate thyroid nodules.
    Ann Surg Oncol. 2015; 22: 3996-4001https://doi.org/10.1245/s10434-015-4486-3
    View in Article

    • Google Scholar
59. • Taye A.
    • Gurciullo D.
    • Miles B.A.
    • et al.
    Clinical performance of a next-generation sequencing assay (ThyroSeq v2) in the evaluation of indeterminate thyroid nodules.
    Surgery. 2018; 163: 97-103
    View in Article

    • Google Scholar
60. • Valderrabano P.
    • Hallanger-Johnson J.E.
    • Thapa R.
    • et al.
    Comparison of postmarketing findings vs the initial clinical validation findings of a thyroid nodule gene expression classifier: a systematic review and meta-analysis.
    JAMA Otolaryngol Head Neck Surg. 2019; 145: 783-792https://doi.org/10.1001/jamaoto.2019.1449
    View in Article

    • Google Scholar
61. • Samulski T.D.
    • LiVolsi V.A.
    • Wong L.Q.
    • et al.
    Usage trends and performance characteristics of a "gene expression classifier" in the management of thyroid nodules: an institutional experience.
    Diagn Cytopathol. 2016; 44: 867-873https://doi.org/10.1002/dc.23559
    View in Article

    • Google Scholar
62. • Khan T.M.
    • Zeiger M.A.
    Thyroid nodule molecular testing: is it ready for prime time?.
    Front Endocrinol (Lausanne). 2020; 11: 590128https://doi.org/10.3389/fendo.2020.590128
    View in Article

    • Google Scholar
63. • Singh Ospina N.
    • Iñiguez-Ariza N.M.
    • Castro M.R.
    Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment.
    BMJ. 2020; 368: l6670https://doi.org/10.1136/bmj.l6670
    View in Article

    • Google Scholar
64. • Sdano M.T.
    • Falciglia M.
    • Welge J.A.
    • et al.
    Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials.
    Otolaryngol Head Neck Surg. 2005; 133: 391-396
    View in Article

    • Google Scholar
65. • Nygaard B.
    • Hegedüs L.
    • Gervil M.
    • et al.
    Radioiodine treatment of multinodular non-toxic goitre.
    BMJ. 1993; 307: 828-832https://doi.org/10.1136/bmj.307.6908.828
    View in Article

    • Google Scholar
66. • Roque C.
    • Santos F.S.
    • Pilli T.
    • et al.
    Long-term effects of radioiodine in toxic multinodular goiter: thyroid volume, function, and autoimmunity.
    J Clin Endocrinol Metab. 2020; 105: dgaa214https://doi.org/10.1210/clinem/dgaa214
    View in Article

    • Google Scholar
67. • Zingrillo M.
    • Torlontano M.
    • Ghiggi M.R.
    • et al.
    Radioiodine and percutaneous ethanol injection in the treatment of large toxic thyroid nodule: a long-term study.
    Thyroid. 2000; 10: 985-989https://doi.org/10.1089/thy.2000.10.985
    View in Article

    • Google Scholar
68. • Haigh P.I.
    • Urbach D.R.
    • Rotstein L.E.
    Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer.
    Ann Surg Oncol. 2005; 12: 81-89https://doi.org/10.1007/s10434-004-1165-1
    View in Article

    • Google Scholar
69. • Adam M.A.
    • Pura J.
    • Gu L.
    • et al.
    Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
    Ann Surg. 2014; 260: 601-607https://doi.org/10.1097/SLA.0000000000000925
    View in Article

    • Google Scholar
70. • Nixon I.J.
    • Ganly I.
    • Patel S.G.
    • et al.
    Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy.
    Surgery. 2012; 151: 571-579https://doi.org/10.1016/j.surg.2011.08.016
    View in Article

    • Google Scholar
71. • Francis D.O.
    • Pearce E.C.
    • Ni S.
    • et al.
    Epidemiology of vocal fold paralyses after total thyroidectomy for well-differentiated thyroid cancer in a medicare population.
    Otolaryngol Head Neck Surg. 2014; 150: 548-557https://doi.org/10.1177/0194599814521381
    View in Article

    • Google Scholar
72. • Aluffi P.
    • Policarpo M.
    • Cherovac C.
    • et al.
    Post-thyroidectomy superior laryngeal nerve injury.
    Eur Arch Otorhinolaryngol. 2001; 258: 451-454https://doi.org/10.1007/s004050100382
    View in Article

    • Google Scholar
73. • Barczyński M.
    • Randolph G.W.
    • Cernea C.R.
    • et al.
    External branch of the superior laryngeal nerve monitoring during thyroid and parathyroid surgery: international neural monitoring study group standards guideline statement.
    Laryngoscope. 2013; 123: 1https://doi.org/10.1002/lary.24301
    View in Article

    • Google Scholar
74. • Cernea C.R.
    • Ferraz A.R.
    • Furlani J.
    • et al.
    Identification of the external branch of the superior laryngeal nerve during thyroidectomy.
    Am J Surg. 1992; 164: 634-639
    View in Article

    • Google Scholar
75. • Jansson S.
    • Tisell L.E.
    • Hagne I.
    • et al.
    Partial superior laryngeal nerve (SLN) lesions before and after thyroid surgery.
    World J Surg. 1988; 12: 522-527https://doi.org/10.1007/BF01655439
    View in Article

    • Google Scholar
76. • Teitelbaum B.J.
    • Wenig B.L.
    Superior laryngeal nerve injury from thyroid surgery.
    Head Neck. 1995; 17: 36-40https://doi.org/10.1002/hed.2880170108
    View in Article

    • Google Scholar
77. • Annebäck M.
    • Hedberg J.
    • Almquist M.
    • et al.
    Risk of permanent hypoparathyroidism after total thyroidectomy for benign disease: a nationwide population-based cohort study from sweden.
    Ann Surg. 2020; https://doi.org/10.1097/SLA.0000000000003800
    View in Article

    • Google Scholar
78. • Cho J.N.
    • Park W.S.
    • Min S.Y.
    Predictors and risk factors of hypoparathyroidism after total thyroidectomy.
    Int J Surg. 2016; 34: 47-52
    View in Article

    • Google Scholar
79. • Ponce de León-Ballesteros G.
    • Velázquez-Fernández D.
    • Hernández-Calderón F.J.
    • et al.
    Hypoparathyroidism after total thyroidectomy: importance of the intraoperative management of the parathyroid glands.
    World J Surg. 2019; 43: 1728-1735https://doi.org/10.1007/s00268-019-04987-z
    View in Article

    • Google Scholar
80. • Rosato L.
    • Avenia N.
    • Bernante P.
    • et al.
    Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in italy over 5 years.
    World J Surg. 2004; 28: 271-276https://doi.org/10.1007/s00268-003-6903-1
    View in Article

    • Google Scholar
81. • Papini E.
    • Monpeyssen H.
    • Frasoldati A.
    • et al.
    2020 european thyroid association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules.
    Eur Thyroid J. 2020; 9: 172-185https://doi.org/10.1159/000508484
    View in Article

    • Google Scholar
82. • Ha E.J.
    • Baek J.H.
    • Kim K.W.
    • et al.
    Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis.
    J Clin Endocrinol Metab. 2015; 100: 1903-1911https://doi.org/10.1210/jc.2014-4077
    View in Article

    • Google Scholar
83. • Trimboli P.
    • Castellana M.
    • Sconfienza L.M.
    • et al.
    Efficacy of thermal ablation in benign non-functioning solid thyroid nodule: a systematic review and meta-analysis.
    Endocrine. 2020; 67: 35-43https://doi.org/10.1007/s12020-019-02019-3
    View in Article

    • Google Scholar
84. • Cesareo R.
    • Palermo A.
    • Benvenuto D.
    • et al.
    Efficacy of radiofrequency ablation in autonomous functioning thyroid nodules. A systematic review and meta-analysis.
    Rev Endocr Metab Disord. 2019; 20: 37-44https://doi.org/10.1007/s11154-019-09487-y
    View in Article

    • Google Scholar
85. • Bennedbaek F.N.
    • Hegedüs L.
    Treatment of recurrent thyroid cysts with ethanol: a randomized double-blind controlled trial.
    J Clin Endocrinol Metab. 2003; 88: 5773-5777https://doi.org/10.1210/jc.2003-031000
    View in Article

    • Google Scholar
86. • Valcavi R.
    • Frasoldati A.
    Ultrasound-guided percutaneous ethanol injection therapy in thyroid cystic nodules.
    Endocr Pract. 2004; 10: 269-275
    View in Article

    • Google Scholar
87. • Cesareo R.
    • Tabacco G.
    • Naciu A.M.
    • et al.
    Long-term efficacy and safety of percutaneous ethanol injection (PEI) in cystic thyroid nodules: a systematic review and meta-analysis.
    Clin Endocrinol (Oxf). 2021; https://doi.org/10.1111/cen.14530
    View in Article

    • Google Scholar
88. • Guglielmi R.
    • Pacella C.M.
    • Bianchini A.
    • et al.
    Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy.
    Thyroid. 2004; 14: 125-131https://doi.org/10.1089/105072504322880364
    View in Article

    • Google Scholar
89. • Nou E.
    • Kwong N.
    • Alexander L.K.
    • et al.
    Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration.
    J Clin Endocrinol Metab. 2014; 99: 510-516https://doi.org/10.1210/jc.2013-3160
    View in Article

    • Google Scholar
90. • Amit M.
    • Rudnicki Y.
    • Binenbaum Y.
    • et al.
    Defining the outcome of patients with delayed diagnosis of differentiated thyroid cancer.
    Laryngoscope. 2014; 124: 2837-2840https://doi.org/10.1002/lary.24744
    View in Article

    • Google Scholar
91. • Jasim S.
    • Baranski T.J.
    • Teefey S.A.
    • et al.
    Investigating the effect of thyroid nodule location on the risk of thyroid cancer.
    Thyroid. 2020; 30: 401-407https://doi.org/10.1089/thy.2019.0478
    View in Article

    • Google Scholar
92. • Tuttle R.M.
    • Fagin J.A.
    • Minkowitz G.
    • et al.
    Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance.
    JAMA Otolaryngol Head Neck Surg. 2017; 143: 1015-1020https://doi.org/10.1001/jamaoto.2017.1442
    View in Article

    • Google Scholar
93. • Persichetti A.
    • Di Stasio E.
    • Coccaro C.
    • et al.
    Inter- and intraobserver agreement in the assessment of thyroid nodule ultrasound features and classification systems: a blinded multicenter study.
    Thyroid. 2020; 30: 237-242https://doi.org/10.1089/thy.2019.0360
    View in Article

    • Google Scholar
94. • Tessler F.N.
    Thyroid nodules and real estate: location matters.
    Thyroid. 2020; 30: 349-350https://doi.org/10.1089/thy.2020.0090
    View in Article

    • Google Scholar